Pharmaceutical grade Erlotinib Hydrochloride, exclusively manufactured, targets EGFR inhibition for effective cancer treatment. See standout features:
Featuring a chemical formula of C22H23N3O4•HCl and a molecular weight of 429.90 g/mol, this drug exhibits solubility in DMSO and minimal solubility in water. For optimal stability, store at -20°C and avoid exposure to light.
Delivering unmatched efficacy and potency, Erlotinib Hydrochloride offers pioneering advancements in oncology medication. Revered for selective inhibition of the epideral growth factor receptor (EGFR) tyrosine kinase, it targets cancer cells while ensuring minimal impact on normal cells.
Erlotinib Hydrochloride is a top-tier pharmaceutical product known for its potent EGFR tyrosine kinase inhibition. It disrupts the growth of cancer cells with marked selectivity, offering considerable advantages over conventional chemotherapy treatments. Widely recognised as an effective remedy for various cancer types, it has considerably changed landscape of oncology treatments.
Erlotinib Hydrochloride's pharmaceutical-grade quality underscores its reliability as an advanced cancer treatment. This remarkably potent medicine ensures targeted and selective EGFR inhibition, instrumental in preventing and controlling cancerous cell growth.
Unlike standard chemotherapy, the selective inhibition offered by Erlotinib Hydrochloride significantly reduces potential side effects, thereby guaranteeing patients the most effective and least damaging treatment.
Trust in the high-quality, dependable supply, and superior efficacy of Erlotinib Hydrochloride in your fight against cancer. This outstanding product is set to make its transformative impact on cancer treatments globally. Place your order now!